[Lipid behavior during hemodialysis using heparin and prostacyclin]

Area of Science:

• Nephrology
• Cardiovascular Science
• Biochemistry

Context:

• Hemodialysis is a life-sustaining treatment for end-stage renal disease.
• Uremic patients often exhibit dyslipidemia and increased cardiovascular risk.
• Traditional anticoagulants like heparin can impact lipid metabolism.

Purpose:

• To investigate the effects of heparin versus prostacyclin on lipid profiles during hemodialysis.
• To compare the lipidic behavior before and after hemodialysis using different anticoagulants.

Summary:

• This study analyzed lipid parameters including apolipoproteins A and B, total cholesterol, triglycerides, and HDL-cholesterol in ten hemodialysis patients.
• Heparin administration resulted in acute, adverse changes in lipid profiles post-hemodialysis.
• Heparin-free dialysis using prostacyclin infusion did not induce significant lipid derangements.

Impact:

• Heparin may contribute to the lipid abnormalities observed in uremic patients undergoing dialysis.
• Prostacyclin shows promise as a safe anticoagulant and therapeutic agent for hemodialysis patients, particularly those with high cardiovascular risk.
• This suggests prostacyclin may be beneficial for uremic individuals with dyslipidemia, atherosclerosis, and hypertension.